1 unknown. 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
Follow Peptide Receptor Radionuclide Therapy (PRRT): new trials by email Literature Review of Peptide Receptor Radionuclide Therapy (PRRT) trials Research Report on Peptide Receptor Radionuclide Therapy (PRRT)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Peptide Receptor Radionuclide Therapy (PRRT) in Tumors With High Expression of Somatostatin Receptors (Phase 2) Lutetium-177 (177Lu)-DOTATOC, Yttrium-90 (90Y)-DOTATOC, 177Lu-DOTATOC + 90Y-DOTATOC - Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy (PRRT) | Not applicable | Unknown | University Hospital of Ferrara | 250 | 2018-07-02 | 2021-03-10 |
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Nerve Tissue (1) · Neuroectodermal Tumors (1)
177Lu-octreotide, DOTA(0)-Tyr(3)- (1) · 90Y-octreotide, DOTA-Tyr(3)- (1) · Lutetium-177 (1) · Yttrium-90 (1)
University Hospital of Ferrara (1)
Italy (1)
2016 (1)